KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Restructuring Costs (2016 - 2025)

Historic Restructuring Costs for Biogen (BIIB) over the last 11 years, with Q4 2025 value amounting to $6.6 million.

  • Biogen's Restructuring Costs rose 2452.83% to $6.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $48.6 million, marking a year-over-year increase of 6092.72%. This contributed to the annual value of $48.6 million for FY2025, which is 6092.72% up from last year.
  • As of Q4 2025, Biogen's Restructuring Costs stood at $6.6 million, which was up 2452.83% from $7.4 million recorded in Q3 2025.
  • Over the past 5 years, Biogen's Restructuring Costs peaked at $98.8 million during Q4 2023, and registered a low of -$700000.0 during Q2 2025.
  • For the 4-year period, Biogen's Restructuring Costs averaged around $26.8 million, with its median value being $10.5 million (2023).
  • In the last 5 years, Biogen's Restructuring Costs skyrocketed by 131142.86% in 2023 and then plummeted by 11060.61% in 2025.
  • Biogen's Restructuring Costs (Quarter) stood at $7.0 million in 2022, then surged by 1311.43% to $98.8 million in 2023, then plummeted by 94.64% to $5.3 million in 2024, then increased by 24.53% to $6.6 million in 2025.
  • Its Restructuring Costs was $6.6 million in Q4 2025, compared to $7.4 million in Q3 2025 and -$700000.0 in Q2 2025.